Dr. Thomas Grabowski directs the Alzheimer Disease Research Center at UW Medicine.
Researchers discover impact of MSUT2 gene and binding protein, offering others a starting point for new therapeutics.
When it comes to preventing Alzheimer's disease, tau could be the answer. Brian Kraemer, a research associate professor of medicine in the Division of
UW Medicine and Kaiser Permanente researchers to study whether degenerative eye diseases offer clues to who will develop Alzheimer’s.
UW Medicine is creating the Garvey Institute for Brain Health Solutions to develop effective new treatments for brain disorders, with foundational funding of $50 million from philanthropists Lynn and Mike Garvey.
Philanthropists Lynn and Mike Garvey establish The Garvey Institute for Brain Health Solutions to investigate the effects of aging, trauma and addiction.
'Alzheimer's, like breast cancer, is not one disease,' says UW Medicine dementia expert Shubhabrata Mukherjee.
Researchers studying Alzheimer’s disease have created an approach to classify those patients, a finding that may be a path to personalized treatments.
A class of drugs called angiotensin-II receptor blockers was associated with benefit for black women and white women and men.
Alzheimer's disease is the most common form of dementia and accounts for 60 to 80 percent of all cases.